21 Matching Annotations
  1. Last 7 days
  2. aacrjournals.org aacrjournals.org
    Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
    2
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/32/10/1946/785097/Phase-II-Trial-of-Ixazomib-Combined-with
  3. aacrjournals.org aacrjournals.org
    PI3K inhibition in combination with tamoxifen in patients with metastatic HR+/HER2- breast cancer: clinical and circulating tumor DNA results
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/32/10/1983/785105/PI3K-Inhibition-in-Combination-with-Tamoxifen-in
  4. aacrjournals.org aacrjournals.org
    Genomic and transcriptomic analysis of high-grade endometrial carcinoma reveals biological heterogeneity and molecular classification challenges
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/6/4/961/784451/Genomic-and-Transcriptomic-Analysis-of-High-Grade
  5. Jun 2026
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    A Deep Learning-Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma Mutations
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13266343/
  7. May 2026
  8. www.sciencedirect.com www.sciencedirect.com
    Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379126002570
  9. aacrjournals.org aacrjournals.org
    Intra-tumoral tertiary lymphoid structures characterized by a B cell-related signature elicit antitumor effect through HAPLN3 in hepatocellular carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerimmunolres/article/14/5/771/784463/Intratumoral-Tertiary-Lymphoid-Structures
  10. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    JIN-A02, a Mutant-Selective Fourth-Generation EGFR inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13133602/
  11. Apr 2026
  12. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Gastric epithelium from BRCA1 and BRCA2 carriers harbors increased double-stranded DNA damage and enhanced growth potential
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13110856/
  13. aacrjournals.org aacrjournals.org
    Spatial multiomic analyses reveal carcinogenic pathways in end-stage renal disease
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerdiscovery/article/16/3/478/774743/Spatial-Multiomic-Analyses-Reveal-Carcinogenic
  14. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Cell-Free DNA–Derived Immune Cell Ratios Uncover Cancer-Associated Systemic Changes
    2
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13075467/
  15. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13055634/
  16. Mar 2026
  17. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13002239/
  18. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12967298/
  19. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Metastatic progression of pheochromocytoma and paraganglioma occurs via parallel evolution
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12963421/
  20. Feb 2026
  21. www.sciencedirect.com www.sciencedirect.com
    Biomimetic hydrogel for the construction of patient-derived bladder cancer organoids with aggressive growth
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004226001616
  22. Jan 2026
  23. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12514755/
  24. Sep 2025
  25. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Cemiplimab in locally advanced or metastatic secondary angiosarcomas (CEMangio): A phase II clinical trial and biomarker analyses
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12402795/
  26. Aug 2025
  27. www.biorxiv.org www.biorxiv.org
    Cyclin-dependent kinase 9 inhibitors as oncogene signaling modulators in combination with targeted therapy for the treatment of colorectal cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2025.08.13.669992v1
  28. Jun 2025
  29. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    SpatialSNV: A novel method for identifying and analyzing spatially resolved SNVs in tumor microenvironments
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12166308/